Gamehost cancels deal with Oncothyreon – BusinessWeek
By admin
|
Gamehost cancels deal with Oncothyreon
BusinessWeek Biotechnology drug developer Oncothyreon Inc. said a deal announced last month to sell its interest in Oncothyreon Canada Inc. for about $8.2 million has … Oncothyreon announces termination of arrangement agreementPR Newswire (press release) |
Share
You must be logged in to send a comment.
Personalized Gene Medicine
| Mesenchymal Stem Cells
| Stem Cell Treatment for Multiple Sclerosis
| Stem Cell Treatments
| Board Certified Stem Cell Doctors
| Stem Cell Medicine
| Personalized Stem Cells Therapy
| Stem Cell Therapy TV
| Individual Stem Cell Therapy
| Stem Cell Therapy Updates
| MD Supervised Stem Cell Therapy
| IPS Stem Cell Org
| IPS Stem Cell Net
| Genetic Medicine
| Gene Medicine
| Longevity Medicine
| Immortality Medicine
| Nano Medicine
| Gene Therapy MD
| Individual Gene Therapy
| Affordable Stem Cell Therapy
| Affordable Stem Cells
| Stem Cells Research
| Stem Cell Breaking Research



March 9th, 2010